comprehensive -WSS

comprehensive

author：leisure time 2025-09-03 03:32:07 - browse：23842

An advisory committee to the Food and Drug Administration will convene on Tuesday to evaluate the benefits of renal denervation, a one-time surgical procedure that works to reduce blood pressure. The promise — and the potential market — is enormous, but the data on how well the procedure works remains contentious.

The committee will evaluate data from two companies vying for market approval: ReCor Medical, a startup owned by Japanese company Otsuka Medical Devices, and device giant Medtronic, both of which have made surgical systems to treat hypertension.

Data from an analysis of three randomized clinical trials of ReCor Medical’s device showed a modest decrease in blood pressure after two months compared to a control group that received a placebo procedure. Medtronic’s late-stage trial showed that renal denervation reduced hypertension when measuring blood pressure in the doctor’s office, but did not show a reduction in blood pressure when patients measured it at home over 24 hours. At-home blood pressure is considered the more accurate measure, as blood pressure levels tend to artificially rise with anxiety in the clinic. Neither study presented serious safety concerns.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： New menopause drug shows promise in relief for hot flashes

hotspot

WSS

Depression: FDA OKs Otsuka Pharmaceuticals digital therapeutic

Doulas covered by Medicaid under New York's new plan

Biotech reporter’s notebook: A sunnier mood at JPM 2024

Depression: FDA OKs Otsuka Pharmaceuticals digital therapeutic

Readout LOUD podcast: 2023 in review, and a look at biotech in 2024

Drug companies' payments and gifts affect physicians' prescribing

knowledge

comprehensive

hotspot

Continuity nursing helped my family in our darkest PICU moments

Alzheimer's risk factor APOE4 may be a distinct form of the disease

Peter Hotez and the public health issue of online harassment

Medicare Advantage 2025 payments will dip, Biden administration says

Virginia high school admissions case could be legal follow

HHS names first

How to save PrEP access — and even expand it

Overprescribed: High cost isn't America's only drug problem

Anesthesiologist group: stop taking Ozempic before surgery

Study: Black kids more likely to die after surgery than white kids

entertainment

GSK to buy asthma

Fauci’s Covid grilling leads GOP to weigh foreign research rules

Depression: FDA OKs Otsuka Pharmaceuticals digital therapeutic

Health and fitness trackers are measuring the wrong things

JPM 2024: Nvidia claims we're in biological revolution. Are we?

The SUPPORT Act is critical to fighting the opioid crisis

explore

hotspot

hotspot

hotspot